Azithramycine

Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.

Cross Reference

Introduction

To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azithramycine?

Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azithramycine

MeSH term MeSH ID Detail
Fetal Membranes, Premature Rupture D005322 4 associated lipids
Fatty Liver D005234 48 associated lipids
Eyelid Diseases D005141 4 associated lipids
Eye Diseases D005128 12 associated lipids
Exanthema D005076 11 associated lipids
Escherichia coli Infections D004927 17 associated lipids
Erythema Nodosum D004893 5 associated lipids
Epiglottitis D004826 1 associated lipids
Enteritis D004751 8 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Elephantiasis, Filarial D004605 4 associated lipids
Elephantiasis D004604 2 associated lipids
Eisenmenger Complex D004541 1 associated lipids
Edema D004487 152 associated lipids
Ectodermal Dysplasia D004476 1 associated lipids
Dyspnea D004417 10 associated lipids
Dysentery, Bacillary D004405 6 associated lipids
Dry Socket D004368 3 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Dog Diseases D004283 5 associated lipids
Digestive System Diseases D004066 3 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Drug Eruptions D003875 30 associated lipids
Cytomegalovirus Infections D003586 7 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Cryptosporidiosis D003457 3 associated lipids
Cross Infection D003428 9 associated lipids
Crohn Disease D003424 12 associated lipids
Corynebacterium Infections D003354 7 associated lipids
Coronary Disease D003327 70 associated lipids
Corneal Opacity D003318 3 associated lipids
Conjunctivitis, Inclusion D003235 4 associated lipids
Conjunctivitis, Bacterial D003234 3 associated lipids
Colitis D003092 69 associated lipids
Ciliary Motility Disorders D002925 2 associated lipids
Chronic Disease D002908 7 associated lipids
Chlamydiaceae Infections D002694 2 associated lipids
Chlamydia Infections D002690 7 associated lipids
Chancroid D002602 4 associated lipids
Uterine Cervicitis D002575 3 associated lipids
Cat-Scratch Disease D002372 4 associated lipids
Cat Diseases D002371 12 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Carcinoma, Basal Cell D002280 6 associated lipids
Burns D002056 34 associated lipids
Bronchiolitis Obliterans D001989 8 associated lipids
Bronchiolitis D001988 6 associated lipids
Boutonneuse Fever D001907 5 associated lipids
Body Weight D001835 333 associated lipids
Blister D001768 16 associated lipids
Bites, Human D001734 2 associated lipids
Birth Weight D001724 23 associated lipids
Bartonella Infections D001474 3 associated lipids
Bacterial Infections D001424 21 associated lipids
Arthritis, Infectious D001170 8 associated lipids
Arthritis D001168 41 associated lipids
Arteriosclerosis D001161 86 associated lipids
Aphasia, Broca D001039 1 associated lipids
Angina, Unstable D000789 14 associated lipids
Anaplasmataceae Infections D000711 3 associated lipids
Anaphylaxis D000707 35 associated lipids
Amebiasis D000562 2 associated lipids
Airway Obstruction D000402 13 associated lipids
Agammaglobulinemia D000361 4 associated lipids
Actinomycetales Infections D000193 4 associated lipids
Acquired Immunodeficiency Syndrome D000163 12 associated lipids
Acne Vulgaris D000152 35 associated lipids
Acinetobacter Infections D000151 4 associated lipids
Achondroplasia D000130 1 associated lipids
Abscess D000038 13 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Abnormalities, Drug-Induced D000014 10 associated lipids
Per page 10 20 50 100 | Total 276

PubChem Associated disorders and diseases

What pathways are associated with Azithramycine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azithramycine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azithramycine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azithramycine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azithramycine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azithramycine?

Mouse Model

Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).

Knock-out

Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).

Tissue Model

Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Azithramycine

Download all related citations
Per page 10 20 50 100 | Total 4404
Authors Title Published Journal PubMed Link
Walsh MS et al. Prevalence of Chlamydia trachomatis infection in Samoan women aged 18 to 29 and assessment of possible risk factors: a community-based study. 2015 Trans. R. Soc. Trop. Med. Hyg. pmid:25732755
Hamasuna R et al. The second nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan, 2012-2013. 2015 J. Infect. Chemother. pmid:25727286
Gershengorn HB et al. The association of antibiotic treatment regimen and hospital mortality in patients hospitalized with Legionella pneumonia. 2015 Clin. Infect. Dis. pmid:25722195
Min KW et al. Education and imaging. Gastrointestinal: a case of histologically confirmed scrub typhus gastritis. 2015 J. Gastroenterol. Hepatol. pmid:25707787
Wessels MR et al. Case records of the Massachusetts General Hospital. Case 6-2015. A 16-year-old boy with coughing spells. 2015 N. Engl. J. Med. pmid:25693017
Principi N et al. Azithromycin use in patients with cystic fibrosis. 2015 Eur. J. Clin. Microbiol. Infect. Dis. pmid:25686729
Zheng H et al. Association of the in vitro susceptibility of clinical isolates of chlamydia trachomatis with serovar and duration of antibiotic exposure. 2015 Sex Transm Dis pmid:25668641
Nemes-Nikodém É et al. [Antimicrobal resistance of Neisseria gonorrhoeae strains in Hungary]. 2015 Orv Hetil pmid:25639637
Kong FY et al. The efficacy of azithromycin and doxycycline for the treatment of rectal chlamydia infection: a systematic review and meta-analysis. 2015 J. Antimicrob. Chemother. pmid:25637520
Sutton AL et al. Perinatal pharmacokinetics of azithromycin for cesarean prophylaxis. 2015 Am. J. Obstet. Gynecol. pmid:25595580
Saini H et al. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections. 2015 Int. J. Antimicrob. Agents pmid:25604277
Krenn K et al. Effects of azithromycin and tanomastat on experimental bronchiolitis obliterans. 2015 J. Thorac. Cardiovasc. Surg. pmid:25595376
Unger HW et al. Sulphadoxine-pyrimethamine plus azithromycin for the prevention of low birthweight in Papua New Guinea: a randomised controlled trial. 2015 BMC Med pmid:25591391
Kwon HJ et al. Megalocytic interstitial nephritis following acute pyelonephritis with Escherichia coli bacteremia: a case report. 2015 J. Korean Med. Sci. pmid:25552891
Hauser C et al. In vitro activity of fosfomycin alone and in combination with ceftriaxone or azithromycin against clinical Neisseria gonorrhoeae isolates. 2015 Antimicrob. Agents Chemother. pmid:25547354
Marks M et al. Yaws. 2015 Br. Med. Bull. pmid:25525120
Kadova Z et al. IL-1 receptor blockade alleviates endotoxin-mediated impairment of renal drug excretory functions in rats. 2015 Am. J. Physiol. Renal Physiol. pmid:25503728
Lu ZK et al. Cardiac risks associated with antibiotics: azithromycin and levofloxacin. 2015 Expert Opin Drug Saf pmid:25494485
Kasai A et al. Prevalence and molecular analysis of macrolide-resistant Moraxella catarrhalis clinical isolates in Japan, following emergence of the highly macrolide-resistant strain NSH1 in 2011. 2015 J. Med. Microbiol. pmid:25934551
Bissessor M et al. Persistence of Neisseria gonorrhoeae DNA following treatment for pharyngeal and rectal gonorrhea is influenced by antibiotic susceptibility and reinfection. 2015 Clin. Infect. Dis. pmid:25371490
Ohara H et al. Azithromycin Can Prolong QT Interval and Suppress Ventricular Contraction, but Will Not Induce Torsade de Pointes. 2015 Cardiovasc. Toxicol. pmid:25367413
Stamm LV Syphilis: antibiotic treatment and resistance. 2015 Epidemiol. Infect. pmid:25358292
Jayarathna YR et al. Analyzing the necessity of prophylactic antibiotic usage in laparoscopy for uncomplicated gynecologic conditions in Sri Lanka. 2015 J. Obstet. Gynaecol. Res. pmid:25331108
Merchan LM et al. Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonization. 2015 Antimicrob. Agents Chemother. pmid:25385115
Schögler A et al. Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial cells. 2015 Eur. Respir. J. pmid:25359346
Dubois J et al. In vitro and intracellular activities of peptide deformylase inhibitor GSK1322322 against Legionella pneumophila isolates. 2015 Antimicrob. Agents Chemother. pmid:25348534
Hodge S et al. Increased CD8 T-cell granzyme B in COPD is suppressed by treatment with low-dose azithromycin. 2015 Respirology pmid:25308201
Li Y et al. Where macrolide resistance is prevalent. 2015 APMIS pmid:25703275
Keenan JD et al. Evidence for clonal expansion after antibiotic selection pressure: pneumococcal multilocus sequence types before and after mass azithromycin treatments. 2015 J. Infect. Dis. pmid:25293366
Luo H et al. Identification of ribosomal RNA methyltransferase gene ermF in Riemerella anatipestifer. 2015 Avian Pathol. pmid:25690020
Sandrock CE and Norris A Infection in severe asthma exacerbations and critical asthma syndrome. 2015 Clin Rev Allergy Immunol pmid:24984968
Aucamp M et al. Amorphous azithromycin with improved aqueous solubility and intestinal membrane permeability. 2015 Drug Dev Ind Pharm pmid:24980913
Young PM et al. Multi-breath dry powder inhaler for delivery of cohesive powders in the treatment of bronchiectasis. 2015 Drug Dev Ind Pharm pmid:24811055
Cabeza J et al. Feasibility of Chlamydia trachomatis screening and treatment in pregnant women in Lima, Peru: a prospective study in two large urban hospitals. 2015 Sex Transm Infect pmid:25107711
Willekens J et al. How long should we maintain long-term azithromycin treatment in cystic fibrosis patients? 2015 Pediatr. Pulmonol. pmid:24464958
Méndez Abad P et al. Idiopathic plastic bronchitis as an uncommon cause of massive pulmonary atelectasis. 2015 Arch. Bronconeumol. pmid:24495947
Maračić S et al. 1,2,3-Triazole pharmacophore-based benzofused nitrogen/sulfur heterocycles with potential anti-Moraxella catarrhalis activity. 2015 Bioorg. Med. Chem. pmid:26578325
Zhang B et al. Azithromycin drives alternative macrophage activation and improves recovery and tissue sparing in contusion spinal cord injury. 2015 J Neuroinflammation pmid:26597676
Cohen RT and Pelton SI Individual Benefit vs Societal Effect of Antibiotic Prescribing for Preschool Children With Recurrent Wheeze. 2015 JAMA pmid:26575058
Roca A et al. Prevention of bacterial infections in the newborn by pre-delivery administration of azithromycin: Study protocol of a randomized efficacy trial. 2015 BMC Pregnancy Childbirth pmid:26585192
Bacharier LB et al. Early Administration of Azithromycin and Prevention of Severe Lower Respiratory Tract Illnesses in Preschool Children With a History of Such Illnesses: A Randomized Clinical Trial. 2015 JAMA pmid:26575060
Hemmige V et al. Recurrent skin and soft tissue infections in HIV-infected patients during a 5-year period: incidence and risk factors in a retrospective cohort study. 2015 BMC Infect. Dis. pmid:26503616
Su XH et al. Multidrug-Resistant Neisseria gonorrhoeae Isolates from Nanjing, China, Are Sensitive to Killing by a Novel DNA Gyrase Inhibitor, ETX0914 (AZD0914). 2015 Antimicrob. Agents Chemother. pmid:26482313
Pogany L et al. Management of gonococcal infection among adults and youth: New key recommendations. 2015 Can Fam Physician pmid:26472793
Jesus FP et al. In Vitro and In Vivo Antimicrobial Activities of Minocycline in Combination with Azithromycin, Clarithromycin, or Tigecycline against Pythium insidiosum. 2015 Antimicrob. Agents Chemother. pmid:26459895
Azzam O et al. Rhodococcus equi peritonitis in continuous ambulatory peritoneal dialysis: a first in Australia. 2015 BMJ Case Rep pmid:26438670
ACOG Committee Opinion No. 645: Dual Therapy for Gonococcal Infections. 2015 Obstet Gynecol pmid:26488526
Shibahara D et al. Falciparum Malaria Incidentally Pretreated with Azithromycin. 2015 Intern. Med. pmid:26424314
ACOG Committee Opinion No. 645 Summary: Dual Therapy for Gonococcal Infections. 2015 Obstet Gynecol pmid:26488518
Wei HX et al. A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans. 2015 PLoS ONE pmid:26394212
Babics A and Roussellier P Gardnerella vaginalis: An overlooked pathogen in male patients? 2015 Med Mal Infect pmid:26472061
See CW et al. The Effect of Mass Azithromycin Distribution on Childhood Mortality: Beliefs and Estimates of Efficacy. 2015 Am. J. Trop. Med. Hyg. pmid:26392160
Winters N et al. Efficacy and safety of World Health Organization group 5 drugs for multidrug-resistant tuberculosis treatment. 2015 Eur. Respir. J. pmid:26381514
Kong FY and Hocking JS Treatment challenges for urogenital and anorectal Chlamydia trachomatis. 2015 BMC Infect. Dis. pmid:26220080
Falk L et al. Time to eradication of Mycoplasma genitalium after antibiotic treatment in men and women. 2015 J. Antimicrob. Chemother. pmid:26283670
Å majs D et al. Macrolide Resistance in the Syphilis Spirochete, Treponema pallidum ssp. pallidum: Can We Also Expect Macrolide-Resistant Yaws Strains? 2015 Am. J. Trop. Med. Hyg. pmid:26217043
Beigelman A et al. Does azithromycin modify viral load during severe respiratory syncytial virus bronchiolitis? 2015 J. Allergy Clin. Immunol. pmid:26215052
Fonseca DC et al. Clinical and Microbiologic Evaluation of Scaling and Root Planing per Quadrant and One-Stage Full-Mouth Disinfection Associated With Azithromycin or Chlorhexidine: A Clinical Randomized Controlled Trial. 2015 J. Periodontol. pmid:26252751
Pereira A et al. Acute onset of widespread pustular eruption. 2015 Aust Fam Physician pmid:26209988
O'Beirne SL et al. Severe Cavitary, Fistulating Mycobacterium avium-intracellulare Complex Disease in an Immunocompetent Host. 2015 Am. J. Respir. Crit. Care Med. pmid:26244303
Zhang L et al. Effects of azithromycin on gene expression profiles of proinflammatory and anti-inflammatory mediators in the eyelid margin and conjunctiva of patients with meibomian gland disease. 2015 JAMA Ophthalmol pmid:26204109
Wilson DW et al. Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum. 2015 BMC Biol. pmid:26187647
Zhanel GG et al. Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data-authors' response. 2015 J. Antimicrob. Chemother. pmid:26242414
Brill SE et al. Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial. 2015 Thorax pmid:26179246
Horner PJ Editorial Commentary: Mycoplasma genitalium and Declining Treatment Efficacy of Azithromycin 1 g: What Can We Do? 2015 Clin. Infect. Dis. pmid:26240204
Medina AM et al. Comparative analysis of antimicrobial resistance in enterotoxigenic Escherichia coli isolates from two paediatric cohort studies in Lima, Peru. 2015 Trans. R. Soc. Trop. Med. Hyg. pmid:26175267
Lau A et al. The Efficacy of Azithromycin for the Treatment of Genital Mycoplasma genitalium: A Systematic Review and Meta-analysis. 2015 Clin. Infect. Dis. pmid:26240201
West SK et al. Risk of Infection with Chlamydia trachomatis from Migrants to Communities Undergoing Mass Drug Administration for Trachoma Control. 2015 Ophthalmic Epidemiol pmid:26158574
Goldstein LH et al. Azithromycin is not associated with QT prolongation in hospitalized patients with community-acquired pneumonia. 2015 Pharmacoepidemiol Drug Saf pmid:26238864
Gebresillasie S et al. Inter-Rater Agreement between Trachoma Graders: Comparison of Grades Given in Field Conditions versus Grades from Photographic Review. 2015 Ophthalmic Epidemiol pmid:26158573
Gualdoni GA et al. Azithromycin inhibits IL-1 secretion and non-canonical inflammasome activation. 2015 Sci Rep pmid:26152605
Unemo M et al. High in vitro susceptibility to the novel spiropyrimidinetrione ETX0914 (AZD0914) among 873 contemporary clinical Neisseria gonorrhoeae isolates from 21 European countries from 2012 to 2014. 2015 Antimicrob. Agents Chemother. pmid:26077246
Cowling CS et al. National trachoma surveillance annual report, 2012. 2015 Commun Dis Intell Q Rep pmid:26063088
Lahra MM Australian Gonococcal Surveillance Programme annual report, 2013. 2015 Commun Dis Intell Q Rep pmid:26063087
Bérard A et al. Use of macrolides during pregnancy and the risk of birth defects: a population-based study. 2015 Pharmacoepidemiol Drug Saf pmid:26513406
Buset SL et al. Non-surgical periodontal therapy supplemented with systemically administered azithromycin: a systematic review of RCTs. 2015 Clin Oral Investig pmid:26063646
Yin SM et al. Disseminated Mycobacterium kansasii disease in complete DiGeorge syndrome. 2015 J. Clin. Immunol. pmid:26048260
Abely M et al. [National consensus regarding azithromycin use in cystic fibrosis]. 2015 Rev Mal Respir pmid:26003196
Escalante MG et al. Comparison of Azithromycin and Amoxicillin Before Dental Implant Placement: An Exploratory Study of Bioavailability and Resolution of Postoperative Inflammation. 2015 J. Periodontol. pmid:26252749
Carter N and Horner P Treatment regimens in non-gonococcal urethritis. 2015 Sex Transm Infect pmid:25990780
Barve A et al. The effects of CYP3A4 induction and inhibition on the pharmacokinetics of alisporivir in humans. 2015 Clin Pharmacol Drug Dev pmid:27128001
Gomi K et al. Full-mouth scaling and root planing combined with azithromycin to treat peri-implantitis. 2015 Aust Dent J pmid:25439282
Schroeck JL et al. Factors associated with antibiotic misuse in outpatient treatment for upper respiratory tract infections. 2015 Antimicrob. Agents Chemother. pmid:25870064
Zhi D et al. The enhancement of cardiac toxicity by concomitant administration of Berberine and macrolides. 2015 Eur J Pharm Sci pmid:25976224
Verleden GM et al. Current views on chronic rejection after lung transplantation. 2015 Transpl. Int. pmid:25857869
Singh AE et al. Gonorrhea Treatment Failures With Oral and Injectable Expanded Spectrum Cephalosporin Monotherapy vs Dual Therapy at 4 Canadian Sexually Transmitted Infection Clinics, 2010-2013. 2015 Sex Transm Dis pmid:25970311
Waites KB et al. In vitro antibacterial activity of AZD0914 against human Mycoplasmas and Ureaplasmas. 2015 Antimicrob. Agents Chemother. pmid:25824220
Unemo M et al. Five-day Azithromycin Treatment Regimen for Mycoplasma genitalium Infection Also Effectively Eradicates Chlamydia trachomatis. 2015 Acta Derm. Venereol. pmid:25823977
Nakamura M et al. Cat-scratch disease presenting as a solitary splenic abscess in an elderly man. 2015 BMJ Case Rep pmid:25804947
Baker KS et al. Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a cross-sectional study. 2015 Lancet Infect Dis pmid:25936611
Phelan VV et al. Mass Spectrometry Analysis of Pseudomonas aeruginosa Treated with Azithromycin. 2015 J. Am. Soc. Mass Spectrom. pmid:25801585
Agaisse H Shigella flexneri serotype 3a: the rise of a superbug. 2015 Lancet Infect Dis pmid:25936610
Jimenez V et al. Mass drug administration for trachoma: how long is not long enough? 2015 PLoS Negl Trop Dis pmid:25799168
Kitsiouli E et al. Effect of azithromycin on the LPS-induced production and secretion of phospholipase A2 in lung cells. 2015 Biochim. Biophys. Acta pmid:25791017
Prohl A et al. Enrofloxacin and macrolides alone or in combination with rifampicin as antimicrobial treatment in a bovine model of acute Chlamydia psittaci infection. 2015 PLoS ONE pmid:25768665
Coolen N et al. Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin. 2015 J. Cyst. Fibros. pmid:25735458
Soares GM et al. Effects of azithromycin, metronidazole, amoxicillin, and metronidazole plus amoxicillin on an in vitro polymicrobial subgingival biofilm model. 2015 Antimicrob. Agents Chemother. pmid:25733510
Parry CM et al. Clinically and microbiologically derived azithromycin susceptibility breakpoints for Salmonella enterica serovars Typhi and Paratyphi A. 2015 Antimicrob. Agents Chemother. pmid:25733500
Shoaib A et al. Determining the role of a probiotic in the restoration of intestinal microbial balance by molecular and cultural techniques. 2015 Genet. Mol. Res. pmid:25730092
Corris PA et al. A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation. 2015 Thorax pmid:25714615